#Japan #Tokyo #pharmaceuticals #JPI Seminar #Supply Issues

JPI Seminar: The Current Challenges of Pharmaceutical Supply

On May 8, 2025, the Japan Planning Institute (JPI) will hold a significant seminar addressing the current challenges surrounding the supply of pharmaceuticals. This event will feature Hiroyuki Sakamaki, a key member of the Ministry of Health, Labour and Welfare's committee on stable supply strategies for medical pharmaceutical products. As a global crisis emerges around pharmaceutical shortages, this seminar aims to provide an in-depth analysis of the situation and the measures being taken both domestically and internationally.

Overview of the Seminar

The issue of pharmaceutical shortages has escalated into a global dilemma, prompting regulatory authorities in advanced countries to implement various strategies to ensure stable supply while addressing shortages. In Japan, the Ministry of Health has advocated for the restructuring of the industry to eliminate the excessive variety of low-volume products. This effort has been partly driven by the manufacturing malpractices associated with generic pharmaceutical companies.

The seminar will focus on the underlying reasons contributing to pharmaceutical shortages in Japan and examine international approaches to resolving such challenges. Participants will be encouraged to contemplate whether the Ministry's strategies will effectively mitigate the issue of shortages and discuss broader directions for promoting the generic pharmaceutical industry while solving the underlying problems.

Seminar Schedule

The seminar is scheduled to run from 9:30 AM to 11:30 AM, with the possibility for attendees to participate either in person or via live streaming. Registered participants can also access archived recordings for two weeks following the event, allowing for convenient and flexible viewing.

Key Topics Discussed

The agenda features a comprehensive look at several critical elements, including:
1. The current state of pharmaceutical supply.
2. Unique factors leading to pharmaceutical shortages in Japan.
3. International measures toward ensuring stable supplies of pharmaceuticals.
4. Discussions regarding Japan's stable supply strategies — their unique features and challenges.
5. Pharmaceutical industry policies aimed at stabilization efforts.
6. A question-and-answer session.
7. Networking session for exchanging business cards and fostering connections between attendees and the lecturer.

This networking session is designed to facilitate personal connections that could prove beneficial for business expansion.

Registration Details

The seminar fees are structured as follows:

• - Individual Registration: ¥37,370 (including tax)
• - Group Registration (2 or more from the same company): ¥32,370 per person
• - Local Government Representatives: Discounted fee of ¥11,000 per person (limited to two participants, available for in-person or live-streaming only).

Please note that although the standard rates are displayed on the registration page, the discounted fees will be detailed in your invoice.

For more information and to register, please visit this link.

Importance of Participation

By attending this seminar, participants will have the unique opportunity to engage with government officials and industry leaders, expanding their professional networks and possibly creating new business ventures. After the seminar, there will also be an opportunity to ask questions and connect further with the lecturers.

In summary, the JPI seminar slated for May 8, 2025, presents an invaluable opportunity to delve into the pressing challenges of pharmaceutical shortages, the regulatory landscape in Japan, and proactive solutions on both national and international fronts.